Rik Derynck
Company: University of California San Francisco
Job title: Professor - Departments of Cell, Tissue Biology & Anatomy
Seminars:
Panel Discussion: Debating the Best Approach to Target TGF-ß 10:45 am
• Which TGF-ß isoform to target to maximize therapeutic potential in IO and minimize adverse risk • Combination approaches vs monotherapy? • Is there one therapeutic approach with greater potential than others?Read more
day: Day One